Search Result "VEGFR-2 tyrosine kinase."
Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 10 Year: 2016 Page: 1000-1040
Author(s): Leilei Shi,Jianfeng Zhou,Jifeng Wu,Yuemao Shen,Xun Li
Anti-angiogenic Agents: A Review on Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) Inhibitors
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 13 Year: 2021 Page: 2540-2564
Author(s): Kang Cheng,Chen-Fu Liu,Guo-Wu Rao
Antiangiogenic Drugs and Tyrosine Kinases
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 462-469
Author(s): Jozsef Timar, Balazs Dome
Tyrosine Kinase Inhibitors
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 5 Year: 2010 Page: 462-483
Author(s): C. Natoli, B. Perrucci, F. Perrotti, L. Falchi, S. Iacobelli
Tyrosine Kinase Update: Role and Response in Cancer Therapy
Journal: Current Cancer Therapy Reviews
Volume: 7 Issue: 2 Year: 2011 Page: 155-166
Author(s): Rosalyn B. Irby, Yixing Jiang
Pharmacophore Generation and 3D-QSAR of Novel 2-(quinazolin-4- ylamino)-[1,4] Benzoquinone Derivatives as VEGFR-2 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 10 Year: 2012 Page: 899-914
Author(s): Mahesh Kumar Teli,Pradeep Hanumanthappa,Rajanikant G. Krishnamurthy
Molecular Design and Clinical Development of VEGFR Kinase Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 7 Issue: 1 Year: 2007 Page: 1379-1393
Author(s): Zhong Haizhen, Bowen Phillip J.
Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2007 Page: 47-60
Author(s): Teruko Tamura, Alexandra Koch
Pharmacophore and Docking Guided Virtual Screening Study for Discovery of Type I Inhibitors of VEGFR-2 Kinase
Journal: Current Computer-Aided Drug Design
Volume: 13 Issue: 3 Year: 2017 Page: 186-207
Author(s): Heena R. Bhojwani,Urmila J. Joshi
Synthesis of Quinazolines as Tyrosine Kinase Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 3 Year: 2009 Page: 246-275
Author(s): Sanjay K. Srivastava, Vivek Kumar, Shiv K. Agarwal, Rama Mukherjee, Anand C. Burman